Cholesterol absorption inhibitor ezetimibe: Risk-benefits and role in treating dyslipidemias

Shizuya Yamashita, Daisaku Masuda, Akifumi Matsuyama

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)465-481
Number of pages17
JournalContemporary Endocrinology
Volume1
DOIs
Publication statusPublished - 01-01-2015

Fingerprint

Anticholesteremic Agents
Dyslipidemias
Ezetimibe

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{359eee4f63744352ace3035aad4bcbc4,
title = "Cholesterol absorption inhibitor ezetimibe: Risk-benefits and role in treating dyslipidemias",
author = "Shizuya Yamashita and Daisaku Masuda and Akifumi Matsuyama",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-60761-424-1_28",
language = "English",
volume = "1",
pages = "465--481",
journal = "Contemporary Endocrinology",
issn = "0196-8653",
publisher = "Humana Press",

}

Cholesterol absorption inhibitor ezetimibe : Risk-benefits and role in treating dyslipidemias. / Yamashita, Shizuya; Masuda, Daisaku; Matsuyama, Akifumi.

In: Contemporary Endocrinology, Vol. 1, 01.01.2015, p. 465-481.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cholesterol absorption inhibitor ezetimibe

T2 - Risk-benefits and role in treating dyslipidemias

AU - Yamashita, Shizuya

AU - Masuda, Daisaku

AU - Matsuyama, Akifumi

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84976588043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976588043&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-424-1_28

DO - 10.1007/978-1-60761-424-1_28

M3 - Article

AN - SCOPUS:84976588043

VL - 1

SP - 465

EP - 481

JO - Contemporary Endocrinology

JF - Contemporary Endocrinology

SN - 0196-8653

ER -